New CLEO™ HOME Flooring Becomes CERTIFIED asthma & allergy friendly® by Prominent Allergy Program
Apr 25, 2018 12:35 pm UTC| Business
WASHINGTON, DC., April 25, 2018 -- The asthma allergy friendly® Certification Program, an independent program established in the United States by AAFA with their partner ASL, helps consumers identify products more...
FFW Corporation Announces Earnings and Special Dividend
Apr 25, 2018 12:35 pm UTC| Business
WABASH, Ind., April 25, 2018 -- FFW Corporation (the “Corporation”) (OTC PINK:FFWC) (4/24/18 Close: $41.99), parent corporation of Crossroads Bank (the “Bank”), announced a special dividend and earnings for the quarter...
Teladoc Announces U.S. Launch of Behavioral Health Navigator
Apr 25, 2018 12:35 pm UTC| Business
PURCHASE, NY, April 25, 2018 -- Teladoc, Inc. (NYSE:TDOC), the world’s largest and most trusted provider of virtual care delivery services, announced today the U.S. launch of Behavioral Health Navigator, bringing...
Cryptobloc Technologies Completes Letter of Intent to Acquire 5000 Cryptomining Machines
Apr 25, 2018 12:32 pm UTC| Business
VANCOUVER, British Columbia, April 25, 2018 -- Cryptobloc Technologies Corp., (“Cryptobloc” or the “Company”) (CSE:CRYP), (OTC:CRYBF), (Frankfurt Stock Exchange:GR9) is pleased to announce the successful completion of a...
Apr 25, 2018 12:32 pm UTC| Business
Pre-treatment Unit Passes First Production Tests Required to Supply BP Singapore Under Three-year Agreement CUPERTINO, CA, April 25, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) announced today that its Universal Biofuels...
Youngevity Announces Asia Convention Event Is Being Held Next Month in Malaysia
Apr 25, 2018 12:32 pm UTC| Business
SAN DIEGO, CA, April 25, 2018 -- Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, today revealed that the Company has received indications that its sales convention to be held next...
Ascendis Pharma A/S Announces Upcoming Investor Presentations
Apr 25, 2018 12:32 pm UTC| Business
COPENHAGEN, Denmark, April 25, 2018 -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet medical needs, today...